J. Hornberger

发表

Electronic Health Records: A Guide for Clinicians and Administrators

J. Hornberger, 2009 .

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

Dan J Stein, Gunn Marit Aasvang, Bernadette A. Thomas, 2015, BDJ.

Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

Bernadette A. Thomas, Alan D. Lopez, Mark D. Huffman, 2015, The Lancet.

Economic analysis of targeting chemotherapy using a 21-gene RT-PCR assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer.

Gary H Lyman, John Hornberger, J. Hornberger, 2005, The American journal of managed care.

Economic implications of 21-gene breast cancer risk assay from the perspective of an Israeli-managed health-care organization.

Ariel Hammerman, John Hornberger, Julie Doberne, 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

P215A Cost–benefit analysis of a 21-gene recurrence score for early stage breast cancer in Singapore

J. Hornberger, G. Lopes, R. Chien, 2011 .

P1-10-04: Cost-Utility of the 21-Gene Breast Cancer Assay (Oncotype DX®) in the Irish Healthcare Setting.

J. Hornberger, R. Chien, L. Lacey, 2011 .

Dan J Stein, Gunn Marit Aasvang, Bernadette A. Thomas, 2015, BDJ.

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

Dan J Stein, Gunn Marit Aasvang, Bernadette A. Thomas, 2015, The Lancet.

Deciding Eligibility for Transplantation When a Donor Kidney Becomes Available

J Hornberger, J. Hornberger, J. Hornberger, 1997, Medical decision making : an international journal of the Society for Medical Decision Making.

The cost-benefit of a randomized trial to a health care organization.

J Hornberger, J. Hornberger, P. Eghtesady, 1998, Controlled clinical trials.

When To Base Clinical Policies on Observational Versus Randomized Trial Data

J Hornberger, J. Hornberger, J. Hornberger, 1997, Annals of Internal Medicine.

A multigene prognostic assay for selection of adjuvant chemotherapy in patients with T3, stage II colon cancer: impact on quality-adjusted life expectancy and costs.

J. Hornberger, G. Lyman, R. Chien, 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

Nobhojit Roy, Anders Larsson, Ivy Shiue, 2014, The Lancet.

A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease

John Hornberger, Alan Garber, J. Hornberger, 2000, American Journal of Gastroenterology.

The economics of treating chronic hepatitis C patients with peginterferon α‐2a (40 kDa) plus ribavirin presenting with persistently normal aminotransferase *

J. Hornberger, S. Zeuzem, D. Prati, 2006, Journal of viral hepatitis.

Comprehensive Evaluations of Health Care Interventions: The Realism-Transparency Tradeoff

J. Hornberger, K. Robertus, 2005, Medical decision making : an international journal of the Society for Medical Decision Making.

A Systematic Review of Cost-Utility Analyses in HIV/AIDS: Implications for Public Policy

J. Hornberger, M. Holodniy, K. Robertus, 2007, Medical decision making : an international journal of the Society for Medical Decision Making.

The VA Point-of-Care Precision Oncology Program: Balancing Access with Rapid Learning in Molecular Cancer Medicine

P. Lavori, J. Hornberger, S. Pyarajan, 2016, Biomarkers in cancer.

The effect of a patient's risk-taking attitude on the cost effectiveness of testing strategies in the evaluation of pulmonary lesions.

J. Hornberger, S. Raab, 1997, Chest.

A Systematic Literature Review of Utilities Associated With Visual Acuity in Retinal Diseases

J. Hornberger, Julie W. Doberne, J. Kowalski, 2008 .

Cost-Effectiveness of a Vaccine To Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults

J. Hornberger, K. Robertus, 2006, Annals of Internal Medicine.

Urine circulating-tumor DNA (ctDNA) detection of acquired EGFR T790M mutation in non-small-cell lung cancer: An outcomes and total cost-of-care analysis.

J. Hornberger, J. Sands, Qianyi Li, 2017, Lung cancer.

Assigning value to medical algorithms: implications for personalized medicine.

J. Hornberger, 2013, Personalized medicine.

Medical resource use in a phase III trial (SO 14796) of XelodaTM (capecitabine) in previously untreated advanced/metastatic colorectal cancer

J. Hornberger, C. Twelves, B. Osterwalder, 1999 .

Clustering and the design of preference-assessment surveys in healthcare.

R. Olshen, K. McDonald, L. Lenert, 1999, Health services research.

Cost-effectiveness analysis of rituximab combined with chop for treatment of diffuse large B-cell lymphoma.

J. Hornberger, J. Best, S. Proctor, 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Computer-assisted quality of life assessment for clinical trials.

L. Lenert, J. Hornberger, 1996, Proceedings : a conference of the American Medical Informatics Association. AMIA Fall Symposium.

Variability among methods to assess patients' well-being and consequent effect on a cost-effectiveness analysis.

D A Redelmeier, D. Redelmeier, J. Hornberger, 1992, Journal of clinical epidemiology.

Comparative effectiveness in personalized medicine-clearly defining the intended use population.

J. Hornberger, 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Proliferative epithelial disease identified in nipple aspirate fluid and risk of developing breast cancer: a systematic review

J. Hornberger, S. Quay, Qianyi Li, 2015, Current medical research and opinion.

An Economic Analysis of Cell-Free DNA Non-Invasive Prenatal Testing in the US General Pregnancy Population

J. Hornberger, M. Rabinowitz, K. Curnow, 2015, PloS one.

P201 Meta-analysis of the decision impact of the 21-gene breast cancer Recurrence Score® in clinical practice

J. Hornberger, R. Chien, 2011 .

A Report of the ISPOR Health Science Committee – Task Force on Good Research Practices – Modeling Studies

B. O'brien, M. Johannesson, M. Weinstein, 2003 .

Bridn ng Language and Cultural Barriers between Physicians and Patients

J. Hornberger, S. R. Wilson, Haruka Itakura, 2006 .

Financial implications of choice of dialysis type of the revised Medicare payment system: an economic analysis.

J. Hornberger, R. Hirth, 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A multivariate analysis of mortality and hospital admissions with high-flux dialysis.

J. Hornberger, A. Garber, J. Petersen, 1992, Journal of the American Society of Nephrology : JASN.

The hemodialysis prescription and quality-adjusted life expectancy. Renal Physicians Association Working Committee on Clinical Guidelines.

J. Hornberger, 1993, Journal of the American Society of Nephrology : JASN.

Author's reply to Lamy.

W. Gradishar, J. Hornberger, H. Gutierrez, 2013, Journal of the National Cancer Institute.

Economic implications of 21-gene recurrence score assay: US multicenter experience.

J. Hornberger, G. Lyman, R. Chien, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Abstract P2-09-06: Meta-Analysis of the Decision Impact of the 21-Gene Breast Cancer Recurrence Score in Clinical Practice

J. Hornberger, R. Chien, 2010 .

Economic analysis of targeting chemotherapy (CT) using a 21 gene RT-PCR assay in lymph node negative (LN-), estrogen receptor positive (ER+) early-stage breast cancer (ESBC).

J. Hornberger, G. Lyman, L. Cosler, 2004, Journal of Clinical Oncology.

Reconstruction of Temporal Hollowing Defect With Anterior-Lateral Thigh Free Flap Following Resection of Recurrent Ameloblastoma of the Infratemporal Fossa and Right Mandible (a Case Report).

J. Hornberger, S. Young, J. Melville, 2016, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

Abstract P6-08-10: Prospective study of the impact of the Prosigna™ assay on adjuvant clinical decision-making in women with estrogen receptor-positive, HER2-negative, node-negative breast cancer: A GEICAM study

J. Hornberger, F. Rojo, J. Albanell, 2015 .

Ethical decision making and patient autonomy: a comparison of physicians and patients in Japan and the United States.

T. Raffin, J. Hornberger, M. Goldstein, 2000, Chest.

The economic impact of psychotherapy: a review.

J. Hornberger, D. Spiegel, G. Gabbard, 1997, The American journal of psychiatry.

Recognition, Diagnosis, and Treatment of Primary Focal Hyperhidrosis on Behalf of the Multi-specialty Working Group on the Recognition, Diagnosis, and Treatment of Primary Focal Hyperhidrosis

Kevin Grimes, John Hornberger, Dee Anna Glaser, 2022 .

Cost-Effectiveness of Repeat Medical Procedures

L. Garrison, J. Hornberger, J. Best, 1997, Medical decision making : an international journal of the Society for Medical Decision Making.

Prostate-specific antigen is not excreted by human kidney or eliminated by routine hemodialysis.

J. Hornberger, J. Kabalin, 1991, Urology.

Computer Modeling of Diabetes and Its Complications

John Hornberger, J. Hornberger, R. Coleman, 2007, Diabetes Care.

Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

Milton C Weinstein, Bryan R Luce, Magnus Johannesson, 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Economic Analysis of a Noninvasive Molecular Pathologic Assay for Pigmented Skin Lesions

J. Hornberger, D. Siegel, 2018, JAMA dermatology.

Cost consequences of HIV-associated lipoatrophy

J. Hornberger, M. Loutfy, A. Shewade, 2008, AIDS care.

Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013: Findings From the Global Burden of Disease 2013 Study.

Dan J Stein, Alan D. Lopez, Timothy M Wolock, 2016, JAMA pediatrics.

Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancer

S. Ferree, J. Hornberger, F. Rojo, 2015, Current medical research and opinion.

A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996-2013.

C. Altar, D. Mrazek, J. Hornberger, 2014, Psychiatric services.

The social and economic burden of treatment-resistant schizophrenia: a systematic literature review

C. Altar, J. Hornberger, J. Kennedy, 2014, International clinical psychopharmacology.

Clinical validity/utility, change in practice patterns, and economic implications of risk stratifiers to predict outcomes for early-stage breast cancer: a systematic review.

W. Gradishar, J. Hornberger, H. Gutierrez, 2012, Journal of the National Cancer Institute.

Impact of a Genomic Classifier of Metastatic Risk on Postprostatectomy Treatment Recommendations by Radiation Oncologists and Urologists.

K. Badani, J. Hornberger, T. Morgan, 2015, Urology.

Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery

K. Badani, D. Albala, J. Hornberger, 2014, BJU international.

Effect of a gene expression-based tissue of origin test's impact on patient management for difficult-to-diagnose primary cancers.

J. Hornberger, G. Varadhachary, W. D. Henner, 2011, Journal of Clinical Oncology.

The Burden of Mental Disorders in the Eastern Mediterranean Region, 1990-2013

Laith J. Abu-Raddad, Jens Christoffer Skogen, Ivy Shiue, 2017, PloS one.

Cost-Effectiveness of Enfuvirtide for Treatment-Experienced Patients with HIV in Italy

J. Hornberger, A. Lazzarin, Jesse Green, 2005, HIV clinical trials.

Title The Burden of Mental Disorders in the Eastern MediterraneanRegion , 1990-2013

Amany, Dan J Stein, T. Vos, 2017 .

Relationship Between Antiretroviral Prescribing Patterns and Treatment Guidelines in Treatment-Naive HIV-1-Infected US Veterans (1992-2004)

P. Volberding, J. Hornberger, T. MaCurdy, 2007, Journal of acquired immune deficiency syndromes.

Cost‐benefit of the 21‐gene Breast Cancer Recurrence Score Assay for Patients in Singapore

J. Hornberger, R. Chien, G. de Lima Lopes, 2013, The breast journal.

US Insurance Program's Experience With a Multigene Assay for Early-Stage Breast Cancer.

John Hornberger, J. Hornberger, R. Chien, 2011, Journal of oncology practice.

Impact of a 21‐gene RT‐PCR assay on treatment decisions in early‐stage breast cancer

J. Hornberger, G. Lyman, L. Cosler, 2007, Cancer.

Cost-effectiveness of rituximab as maintenance therapy in patients with follicular non-Hodgkin lymphoma after responding to first-line rituximab plus chemotherapy

J. Hornberger, R. Chien, C. Reyes, 2012, Leukemia & lymphoma.

Economic evaluation of rituximab plus cyclophosphamide, vincristine and prednisolone for advanced follicular lymphoma

D. Lubeck, J. Hornberger, C. Reyes, 2008, Leukemia & lymphoma.

Economic Analysis of Kiva VCF Treatment System Compared to Balloon Kyphoplasty Using Randomized Kiva Safety and Effectiveness Trial (KAST) Data.

J. Hornberger, D. Beall, W. Olan, 2015, Pain physician.

Serious Adverse Events Associated with Readmission Through One Year After Vertebral Augmentation with Either a Polyetheretherketone Implant or Balloon Kyphoplasty.

D. Bloch, J. Hornberger, J. Coe, 2017, Pain physician.

Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for the treatment of previously untreated chronic lymphocytic leukemia

J. Hornberger, H. Gutierrez, M. Keating, 2012, Leukemia & lymphoma.

Rechargeable Spinal Cord Stimulation Versus Nonrechargeable System for Patients With Failed Back Surgery Syndrome: A Cost-Consequences Analysis

J. Hornberger, Krishna Kumar, M. Clark, 2008, The Clinical journal of pain.

The cost‐effectiveness of bortezomib in relapsed/refractory multiple myeloma: Swedish perspective

J. Hornberger, J. Aschan, R. Dhawan, 2010, European journal of haematology.

Community oncology in an era of payment reform.

J. Hornberger, J. Temel, B. McAneny, 2014, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

The West German Study Group Breast Cancer Intrinsic Subtype study: a prospective multicenter decision impact study utilizing the Prosigna assay for adjuvant treatment decision-making in estrogen-receptor-positive, HER2-negative early-stage breast cancer

H. Tesch, J. Hornberger, N. Harbeck, 2016, Current medical research and opinion.

Cost-effectiveness of combinatorial pharmacogenomic testing for treatment-resistant major depressive disorder patients.

J. Hornberger, B. Quinn, Qianyi Li, 2015, The American journal of managed care.

Cost-effectiveness analysis of a multivariate index assay compared to modified American College of Obstetricians and Gynecologists criteria and CA-125 in the triage of women with adnexal masses

J. Hornberger, R. Bristow, G. Forde, 2016, Current medical research and opinion.

Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapy

C. Altar, D. Mrazek, J. Hornberger, 2013, International review of psychiatry.

Designing a cost-effective clinical trial.

J Halpern, J. Hornberger, J. Halpern, 1995, Statistics in Medicine.

The cost-effectiveness of treating women with a cervical vaginal smear diagnosis of atypical squamous cells of undetermined significance.

J. Hornberger, S. Raab, A. Steiner, 1998, American journal of obstetrics and gynecology.

Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest group.

Katherine Payne, David Veenstra, Uwe Siebert, 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Minimum Data Needed on Patient Preferences for Accurate, Efficient Medical Decision Making

D A Bloch, J. Hornberger, J C Hornberger, 1995, Medical care.

Clinical and cost implications of amyloid beta detection with amyloid beta positron emission tomography imaging in early Alzheimer’s disease – the case of florbetapir

Ian A. Watson, J. Hornberger, J. Bae, 2017, Current medical research and opinion.

Cost-effectiveness of gene-expression profiling for tumor-site origin.

J. Hornberger, S. Raab, H. Gutierrez, 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B‐cell lymphoma

J. Hornberger, J. Best, 2005, Cancer.

Cost‐effectiveness of rituximab (MabThera®) in diffuse large B‐cell lymphoma in the Netherlands

J. Hornberger, P. Lugtenburg, P. Huijgens, 2005, European journal of haematology.

Health Care Coverage Decision Making in Low- and Middle-Income Countries: Experiences from 25 Coverage Schemes.

J. Hornberger, S. Nishtar, H. Gutierrez, 2014, Population health management.

5161 POSTER Decision Impact and Economic Evaluation of the 21-gene Recurrence Score (RS) Assay for Physicians and Patients in Japan

J. Hornberger, H. Takei, R. Chien, 2011 .

Comparative Economics of a 12-Gene Assay for Predicting Risk of Recurrence in Stage II Colon Cancer

J. Hornberger, S. Dakhil, S. Alberts, 2014, PharmacoEconomics.

Patient preferences in coronary revascularization.

J. Hornberger, M. Hlatky, D. Bloch, 1999, American heart journal.

Societal cost-effectiveness analysis of the 21-gene assay in estrogen-receptor–positive, lymph-node–negative early-stage breast cancer in Japan

J. Hornberger, Seigo Nakamura, C. Yoshizawa, 2014, BMC Health Services Research.

Outcome and economic implications of proteomic test-guided second- or third-line treatment for advanced non-small cell lung cancer: extended analysis of the PROSE trial.

F. Hirsch, J. Hornberger, R. Page, 2015, Lung cancer.

Influence of a genomic classifier on post-operative treatment decisions in high-risk prostate cancer patients: results from the PRO-ACT study

J. Hornberger, K. Yousefi, P. Yohannes, 2014, Current medical research and opinion.

The clinical and economic implications of specimen provenance complications in diagnostic prostate biopsies.

P. Schellhammer, J. Hornberger, K. Wojno, 2015, The Journal of urology.

Effects of a self-administered previsit questionnaire to enhance awareness of patient’s concerns in primary care

J. Hornberger, D. Thom, T. MaCurdy, 1997, Journal of General Internal Medicine.

Outcomes and costs of incorporating a multibiomarker disease activity test in the management of patients with rheumatoid arthritis

K. Michaud, V. Strand, J. Hornberger, 2015, Rheumatology.

Ethical Decision Making and Patient Autonomy *

T. Raffin, J. Hornberger, M. Goldstein, 2000 .

Eliminating language barriers for non-English-speaking patients.

D. Bloch, J. Hornberger, Daniel A. Bloch, 1996, Medical care.

Variation among quality-of-life surveys. Theory and practice.

L. Lenert, J. Hornberger, 1996, Medical care.

Changes in management and survival outcomes for patients receiving gene-expression-based tissue-of-origin test results for difficult-to-diagnose primary cancers.

J. Hornberger, H. Gutierrez, G. Varadhachary, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Laboratory-developed test--SynFRAME: an approach for assessing laboratory-developed tests synthesized from prior appraisal frameworks.

J. Hornberger, Julie W. Doberne, R. Chien, 2012, Genetic testing and molecular biomarkers.

Cost-effectiveness of peginterferon alfa-2a (40kDa) plus ribavirin in patients with HIV and hepatitis C virus co-infection.

John Hornberger, Francesca J Torriani, J. Hornberger, 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

A Promising New Strategy to Improve Treatment Outcomes for Patients with Depression

D. Nash, J. Hornberger, G. Carpenter, 2019, Population health management.

AReviewoftheClinical,Economic, andSocietalBurdenofTreatment- ResistantDepression:1996-2013

D. Mrazek, J. Hornberger, A. Altar, 2014 .

Cost-effectiveness of enfuvirtide in HIV therapy for treatment-experienced patients in the United States.

J. Hornberger, Jesse Green, N. Wintfeld, 2006, AIDS research and human retroviruses.

PGI5 COST-EFFECTIVENESS OF TREATING ADULTS WITH CHRONIC HEPATITIS C (CHC) AND PERSISTENTLY NORMAL ALANINE AMINOTRANSFERASE (PNALT) WITH PEGINTERFERON ALFA-2A (40KD) (PEGASYS) PLUS RIBAVIRIN (COPEGUS)

J. Hornberger, Jesse Green, D. Prati, 2004 .

The importance of sputum cytology in the diagnosis of lung cancer: a cost-effectiveness analysis.

T. Raffin, J. Hornberger, S. Raab, 1997, Chest.

Broadening the perspective when assessing evidence on boosted protease inhibitor-based regimens for initial antiretroviral therapy

J. Hornberger, K. Simpson, R. Baran, 2010, Advances in therapy.

CN1 ECONOMIC EVALUATION OF CAPECITABINE-DOCETAXEL COMBINATION TREATMENT OF METASTATIC BREAST CANCER: A MICRO-SIMULATION STUDY

J. Hornberger, J. O’Shaughnessy, C. Jamieson, 2002 .

Obstacles and Proposed Solutions to Effective Antiretroviral Therapy in Resource-Limited Settings

J. Hornberger, J. Bartlett, M. Bhor, 2009, Journal of the International Association of Physicians in AIDS Care.

Bridging language and cultural barriers between physicians and patients.

J. Hornberger, S. R. Wilson, H. Itakura, 1997, Public health reports.

Further Consideration of the Pigmented Lesion Assay-Reply.

J. Hornberger, D. Siegel, 2019, JAMA dermatology.

Involving Patients in the Cadaveric Kidney Transplant Allocation Process: A Decision-Theoretic Perspective

John Hornberger, Jae-Hyeon Ahn, J. Hornberger, 1996 .

Response from the authors

J. Hornberger, 2011 .

INTRODUCTION TO BAYESIAN REASONING

J Hornberger, J. Hornberger, 2001, International Journal of Technology Assessment in Health Care.

A cost-benefit analysis of a cardiovascular disease prevention trial, using folate supplementation as an example.

J Hornberger, J. Hornberger, 1998, American journal of public health.

The hemodialysis prescription and cost effectiveness. Renal Physicians Association Working Committee on Clinical Guidelines.

J. Hornberger, J C Hornberger, 1993, Journal of the American Society of Nephrology : JASN.

Capecitabine plus docetaxel combination therapy

J. Hornberger, D. Miles, J. O’Shaughnessy, 2005, Cancer.

Significance of prospective multicenter decision impact WSG-BCIST Study in postmenopausal ER+ HER2- N0 early breast cancer (EBC) for molecular testing for intrinsic subtype definition.

H. Tesch, J. Hornberger, N. Harbeck, 2015 .

Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna® Test in the management of early-stage breast cancers

A. Salomon, R. Rouzier, J. Hornberger, 2017, PloS one.

The impact of a serum based proteomic mass spectrometry test on treatment recommendations in advanced non-small-cell lung cancer

J. Hornberger, R. Nelson, W. Akerley, 2013, Current medical research and opinion.

Recognition, diagnosis, and treatment of primary focal hyperhidrosis.

J. Hornberger, M. Naumann, Kevin Grimes, 2004, Journal of the American Academy of Dermatology.

Clinical utility of gene-expression profiling for tumor-site origin in patients with metastatic or poorly differentiated cancer: impact on diagnosis, treatment, and survival

J. Hornberger, M. Amin, H. Gutierrez, 2012, Oncotarget.

Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

Bernadette A. Thomas, Alan D. Lopez, Mark D. Huffman, 2015, The Lancet.

Cost-Effectiveness of Florbetapir-PET in Alzheimer's Disease: A Spanish Societal Perspective.

J. Hornberger, M. Happich, T. Dilla, 2015, The journal of mental health policy and economics.

The Burden of Mental Disorders in the Eastern Mediterranean Region, 1990-2013

Dan J Stein, T. Vos, C. Murray, 2017, PloS one.

Clinical Investigations: CancerThe Importance of Sputum Cytology in the Diagnosis of Lung Cancer: A Cost-effectiveness Analysis

T. Raffin, J. Hornberger, S. Raab, 1997 .

Use of a multigene prognostic assay for selection of adjuvant chemotherapy in patients with stage II colon cancer: Impact on quality-adjusted life expectancy and costs.

J. Hornberger, G. Lyman, R. Chien, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.